Stay updated on Alvocidib Biomarker AML Phase 2 Clinical Trial

Sign up to get notified when there's something new on the Alvocidib Biomarker AML Phase 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alvocidib Biomarker AML Phase 2 Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, updating the site’s revision label from v3.6.2 to reflect a newer version.
    Difference
    0.0%
    Check dated 2026-07-04T00:00:13.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.2) replacing the previous v3.6.0, signaling an underlying software update behind the page; no study details or displayed content appear to be affected.
    Difference
    0.0%
    Check dated 2026-06-27T00:07:42.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now shows that the study is no longer looking for participants, signaling that enrollment has ceased. It also includes new help/navigation items and a formatting change to the Intervention/Treatment header as part of a UI/text refresh.
    Difference
    0.4%
    Check dated 2026-06-12T16:41:10.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4. This represents a version update with no changes to the study content.
    Difference
    0.0%
    Check dated 2026-06-05T13:17:08.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, updating the site revision from the previous v3.5.3. This indicates a software/version update rather than a change to the study data or layout.
    Difference
    0.0%
    Check dated 2026-05-15T05:52:00.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision changed from v3.5.2 to v3.5.3 on the page, indicating a deployed update to the study entry. This version bump does not modify the study information presented to users.
    Difference
    0.0%
    Check dated 2026-04-30T18:36:03.000Z thumbnail image

Stay in the know with updates to Alvocidib Biomarker AML Phase 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alvocidib Biomarker AML Phase 2 Clinical Trial page.